1.1|9|11|95|1pter-p36.13|CCV|P|Cataract, congenital, Volkmann type||115665|Fd|linked to Rh in Scottish family||Cataract, congenital, Volkmann type (2)| | ||
1.2|9|25|01|1p36.23|ENO1, PPH, MPB1|C|Enolase-1, alpha||172430|S, F, R, REa|||Enolase deficiency (1)| | |4(Eno1)|
1.3|12|22|87|1pter-p36|ERPL1, HLM2|C|Endogenous retroviral pol gene-like sequence 1 (oncogene HLM2)||131190|REa, F|||| | ||
1.4|4|14|11|1p36.11|HMGCL|P|3-hydroxy-3-methylglutaryl-Coenzyme A lyase||613898|REa, A|||HMG-CoA lyase deficiency, 246450 (3)| | |4(Hmgcl)|
1.5|11|3|09|1p36.33|AGRN|P|Agrin||103320|REa|||Myasthenia, limb-girdle, familial, 254300 (3)| | |4(Agrn)|
1.6|3|15|92|1p36.33|GNB1|C|Guanine nucleotide-binding protein, beta polypeptide-1||139380|REa, A|||| | |4(Gnb1)|
1.7|10|2|07|1p35.2|SDC3, SYND3, SDCN|C|Syndecan 3||186357|REc, R, H|||{Obesity, association with}, 601665 (3)| | |4(Synd3)|
1.8|8|28|98|1pter-p22.1|SAI1, MTS1, TFS1|C|Suppression of anchorage independence-1 (malignant transformation|suppression-1)|154280|S, H|||| | |4(Tfs1)|
1.9|10|6|08|1p36.33|ATAD3A|P|ATPase family, AAA domain-containing, member 3A||612316|REc|||| | ||
1.10|10|6|08|1p36.33|ATAD3B, TOB3, KIAA1273|C|ATPase family, AAA domain-containing, member 3B||612317|R, REC|||| | ||
6.412|12|21|09|6p21.1|PRPH2, DS, RP7, PRPH, AVMD, AOFMD, CACD2|C|Peripherin 2, mouse, homolog of||179605|REa, A|digenic RP with ROM1||Retinitis pigmentosa 7, 608133 (3); Retinitis punctata albescens,|136880 (3); Macular dystrophy, patterned, 169150 (3); Macular dystrophy, vitelliform, 608161 (3); Foveomacular dystrophy, adult-onset, with choroidal|neovascularization, 608161 (3); Macular dystrophy (3); Retinitis pigmentosa, digenic, 608133 (3); Choriodal dystrophy, central areolar 2, 613105 (3)|17(rds)|Farrar (1991); Kajiwara (1991)